WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals
World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

ISSN 2457-0400

Impact Factor  :  5.464

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR New Impact Factor

    Its our Pleasure to Inform you that WJAHR Impact Factor has been increased from  4.897 to 5.464 due to high quality Publication at International Level

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: JUNE ISSUE PUBLISHED

    JUNE 2022 Issue has been successfully launched on 1 June 2022

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR 1 June Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

ANALYSIS OF DYSLIPIDAEMIC PATTERN OF INDIAN TYPE 2 DIABETES INDIVIDUALS USING AMERICAN DIABETES ASSOCIATION GUIDELINES

R. Anil Kumar*

ABSTRACT

Aims and Objectives-To analyse the lipid parameters of type 2 diabetes individuals not on any anti lipid drugs using American diabetes association guidelines. Methods --200 type 2 diabetes individuals attending out-patient department of Karnataka institute of endocrinology and research were randomly selected. They should not be taking any anti lipid medications. Fasting plasma glucose, post prandial plasma glucose, HBA1c, lipid profile, BMI, waist circumference and BP of these subjects were measured. Results- Diabetes subjects were in the age range of 20 to 70 years and 67.5% were males. The duration of diabetes was between new to 20 years. Family history was positive in 47% of the subjects. Hypertension was present in 37% of the subjects. LDL was <100, 100-129, 130-159, 160-189 and >190mg/dl were present in 23%, 34%, 20%, 9% and 2% of the diabetes subjects. HDL was less than 40 mg/dl in 67%, 40 to 60 mg/dl in 32.5% and more than 60 mg/dl in 0.5% of the diabetes subjects. Triglycerides were <150, 150-199, 200-499 and more than 500 mg/dl in 40%, 21.5%, 31.5% and 7% of the diabetes subjects. So the LDL and Triglyceride targets were achieved in 23%, 40% of the individuals respectively. HDL levels of 45 mg/dl in men and 55 mg/dl in women were achieved in only 12.6% and 7.7% respectively. Conclusions- The proportion of type 2 diabetes patients with lipid levels outside of clinical target values was high. Patients with established dyslipidaemia will require advice regarding diet, exercise and improvement in glycaemic control. This study suggests that an active strategy of early detection and drug treatment for dyslipidaemia is needed for 80 to 90% of type 2 diabetic patients.

[Full Text Article]